Cell Line Development
Stable CHO/HEK cell lines engineered for multi-g/L productivity. Complete clone screening, productivity optimization, and monoclonality documentation.
Learn more →
Accepting new programs
From sequence to scalable biologics.
ArtProtein partners with you to develop, scale, and characterize complex biologics using robust CHO/HEK platforms — from first stable clone through IND-ready documentation.
CHO / HEK
Expression Platforms
mAbs & Proteins
Molecule Focus
IND-Ready
Documentation Output
End-to-End
Program Engagement
Our capabilities
What we do
We support biologics programs across the full development lifecycle — from first stable clone to a regulatory-ready technical package.
Process Development
DoE-driven upstream and downstream processes designed for reliable tech transfer. Scalable fed-batch, purification strategies, and robustness studies.
Learn more →Analytical Development
Fit-for-purpose analytical methods and characterization. Method development, product characterization, and comparability packages aligned with regulatory expectations.
Learn more →Regulatory Documentation
Technical content for CMC sections and supporting appendices to streamline IND/IMPD submissions. Risk-based approach to qualification and documentation.
Learn more →Your journey
The biologics development pipeline
A science-driven approach that takes your molecule from idea to IND-ready package.
Sequence & Strategy
Molecule review, expression strategy, risk assessment
Cell Line Development
Transfection, clone screening, stability studies
Process Development
Upstream scale-up, DSP optimization, robustness
Analytical Package
Characterization, methods, comparability
IND-Ready Package
CMC documentation, regulatory submission support
From the lab
Insights & resources
Technical perspectives on biologics development from the ArtProtein team.
Cell Line Development
Five Critical Parameters in CHO Cell Line Development
When selecting a production clone for your biologic, these five parameters determine whether you end up with a robust, scalable process or a development nightmare downstream.
Process Development
Understanding DoE in Upstream Process Optimization
Design of Experiments is not just a buzzword — it's the most efficient path to a robust, transferable upstream process. Here's how we apply it.
Regulatory
IND-Enabling Studies: What Your Analytical Package Needs
Preparing for your first IND submission? A practical checklist of the analytical data and documentation your CMC section will require.
Ready to advance your biologic?
Whether you're at sequence stage or scaling an existing process, ArtProtein can help. Tell us about your program.